STXS — Stereotaxis, Inc.

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1289340 ·
Last close
$1.26
Market Cap
$125.53M
52W High
$2.10
52W Low
$1.24
ADV30
1,157,922
Next earnings
2026-08-11
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 6,291,000 3,794,000 -5,981,000 -5,861,000 54,030,000 14,616,000 34,432,000
Dec 2025 8,642,000 4,327,000 -5,649,000 -5,531,000 52,251,000 13,421,000 33,530,000
Sep 2025 7,464,000 4,101,000 -6,557,000 -6,463,000 45,587,000 10,506,000 34,053,000
Jun 2025 8,798,000 4,579,000 -3,977,000 -3,826,000 41,173,000 6,967,000 34,421,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-15,348,000
Investing CF
$-172,000
Financing CF
$19,447,000
CapEx
$-161,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.24
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-589,229,000
Inventory
$10,495,000
Receivables
$9,619,000
ST Investments
EBIT TTM
$-22,164,000
Pretax Income TTM
$-21,681,000
Interest Exp TTM
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$31,196,000
EBITDA
$-18,159,000
Free Cash Flow
$-8,817,875
Enterprise Value
$125,893,808
Total Cash
$14,616,000
Total Debt
$5,280,000
Shares Out
99,628,561
Trailing EPS
$-0.24
Book Value
$0.15
ROE
-156.1%
ROA
-24.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 32,377,000 -22,112,000 -21,643,000 52,251,000 33,530,000 -13,685,000
Dec 2024 26,918,000 -24,739,000 -24,045,000 46,724,000 35,292,000 -8,497,000
Dec 2023 26,771,000 -21,839,000 -20,713,000 41,909,000 19,989,000 -9,139,000
Dec 2022 28,147,000 -18,776,000 -18,292,000 53,413,000 21,484,000 -8,415,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.13

Max Pain — expiry 2026-08-21

max pain strike: $2.50 · spot: $1.26 · call oi: 1,479 · put oi: 72
Expected Move to 2026-08-21: ±$1.24 (98.02%) — implied range $0.02$2.49 · ATM straddle on $2.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
AVHHL AVITA Medical, Inc. $135.42M $0.88
RCEL AVITA Medical, Inc. $135.42M $4.40
MBOT Microbot Medical Inc. $115.52M $1.72
CVRX CVRx, Inc. $137.32M $5.18
STIM Neuronetics, Inc. $137.78M $1.98

News headlines (Yahoo Finance, 1h cache)

Veracyte (VCYT) Q2 Earnings and Revenues Surpass Estimates
2026-07-30 22:00 · Yahoo
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
2026-07-21 13:00 · Yahoo
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
2026-07-20 12:31 · Yahoo
Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings
2026-07-20 12:07 · Yahoo
Can ISRG Defend Its Leadership as Global Competition Intensifies?
2026-07-15 16:05 · Yahoo
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?
2026-07-10 18:10 · Yahoo
Stereotaxis closes Robocath takeover
2026-07-09 17:00 · Yahoo
Stereotaxis Completes Acquisition of Robocath
2026-07-09 12:08 · Yahoo
Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS)
2026-06-30 02:04 · Yahoo
ISRG's Capital Placement Surge: Demand Strength or Upgrade Cycle Peak?
2026-06-15 14:31 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.